Tar

Clinics in Dermatology

Volumn 15, Issue 5, 1997, Pages 739-744

  Peter Arnold, W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACENE; ARSENIC; BENZO[A]PYRENE; BENZ[A]ANTHRACENE; COAL TAR; COLECALCIFEROL; CORTICOSTEROID; CYTOCHROME P450; DIBENZ[A,H]ANTHRACENE; DITHRANOL; DNA; FLUORANTHENE; ICHTHAMMOL; LEUKOTRIENE B4; LIPID; LIPOXYGENASE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; METHOTREXATE; PARAFFIN; POLYCYCLIC AROMATIC HYDROCARBON; POLYSORBATE 20; POLYSORBATE 80; PSORALEN; PYRENE; RETINOIC ACID; TAR; UNINDEXED DRUG; UNSPECIFIC MONOOXYGENASE; ZINC;

BRONCHOSPASM; DRUG CARCINOGENICITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; PUVA; REVIEW; RISK BENEFIT ANALYSIS; SKIN ALLERGY; SKIN ATROPHY; SKIN CANCER; SKIN DISCOLORATION; TERATOGENICITY; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET B RADIATION;

EID: 0030798684     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(97)00018-7     Document Type: Article

References (54)

1. Bechter J, Serie H. British Patent No. 214,1681.
2. Pott P. Clinical observation relative to the cataract; the polyp of the nose, the cancer of the scrotum, the different kinds of rupture and the mortification of the toes and feet. London: Haus, Clark & Collins, 1775.
3. Müller SA. Topical treatment of psoriasis with tar. Acta Derm Venereol Suppl (Stockh) 1983;112:7-10.
4. Van der Hoek JCS, van Joost T, Stolz E. Sensibilisatie voor pix liquida (houtteer): een persisterend probleem. Ned Tijdschr Geneeskd 1985;129:205-8.
5. Anonymous. International Agency for Research on Cancer. Polynuclear aromatic compounds: Part 4, Bitumens, coal tars and derived products, shale oil and soots. IARC Monograph, Vol 35. 1985.
6. Rasmussen JE. The crudeness of coal tar. Prog Dermatol 1978;12:23-9.
7. Wrench R, Britten AZ. Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. High and low temperature tars and their constituents. Br J Dermatol 1975;92:569-74.
8. Chapman RS, Finn OA. An assessment of high and low temperature tars in psoriasis. Br J Dermatol 1976;94:71-4.
9. Gloor M, Kellermann H. Tierexperimentelle Untersuchungen zur sebosuppressiven Wirkung von Steinkohlenteer. Dermatol Monatsschr 1977;163:550-3.
10. Gloor M, Dressel M, Schnyder UW. The effect of coal tar distillate, cadmium sulphide, ichthyol sodium and omadine MDS on the epidermis of the guinea pig. Dermatologica 1978;156:238-43.
11. Wrench R. Scale prophylaxis. A new antiparakeratotic assay. Arch Dermatol 1981;117:213-5.
12. Fulton JE Jr, Pay SR, Fulton JE 3d. Comedogenicity of current therapeutic products, cosmetics, and ingredients in the rabbit ear. J Am Acad Dermatol 1984;10:96-105.
13. Diezel W, Gruner S, Anhalt GJ. ATPase positive epidermale Langerhans-Zellen: Hemmung der ATPase durch Ammonium-bituminosulfonat (Ichthyol) und Pix lithanthracis. Hautarzt 1992;43:22-4.
14. Gruner S, Zwirner A, Strunk D, et al. The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice. Contact Dermatitis 1992;26:241-7.
15. Fischmeister I, Hellgren L, Vincent J. Infrared spectroscopy for tracing of topically applied ointment vehicles and active substances on healthy skin. Arch Dermatol Res 1975;253:63-9.
16. Gloor M. Aspekte zur Therapie der Seborrhoea oleosa und der Pityriasis simplex capillitii. Hautarzt 1979;30:236-41.
17. Bernd A, Wehrenberg O, Hevert F, et al. Experimenteller und klinischer Nachweis der antiproliferativen Wirkung einer hochgereinigten Steinkohlenteer-Fraction in einer speziellen Gelgrundlage. Arzneimittelforschung 1988;38:582-6.
18. Green CM, Ferguson J, MacLeod TM, et al. Polymorphonuclear leucocyte chemotaxis in response to leukotriene B4 in treated and untreated psoriatics. Dermatologica 1989;178:20-2.
19. Arnold WP, Glade CP, Mier PD, et al. Effects of sphingosine, isoquinoline and tannic acid on the human tapestripping model and the psoriatic lesion. Skin Pharmacol 1993;6:193-9.
20. Foreman MJ, Taylor M, Clark C, et al. Isoquinoline is a possible anti-psoriatic agent in coal tar. Br J Dermatol 1985;112:323-8.
21. Watts P, Stables GS, Akhurst RJ, et al. Localization of transforming growth factor alpha RNA and protein in the skin of psoriatic patients receiving therapy, Br J Dermatol 1994;131:64-71.
22. Unna PJ. Experimentelle Untersuchungen über die photodynamische Wirksamkeit von Steinkohlenteerbestandteilen. Thesis. University of Hamburg, Hamburg, 1957.
23. Tannenbaum L, Parrish JA, Pathak MA, et al. Tar phototoxicity and phototherapy for psoriasis. Arch Dermatol 1975;111:467-70.
24. Dodd WA. Tars. Their role in the treatment of psoriasis. Dermatol Clin 1993;11:131-5.
25. Young E. The external treatment of psoriasis. A controlled investigation of the effects of coal tar. Br J Dermatol 1970;82:510-5.
26. Finlay AY, Young DW. Short contact crude coal tar therapy for psoriasis. Clin Exp Dermatol 1985;10:371-4.
27. Williams REA, Tillman DM, White SI, et al. Re-examining crude coal tar treatment for psoriasis. Br J Dermatol 1992;126:608-10.
28. Stern RS. The benefits, costs and risks of topical tar preparations in the treatment of psoriasis: considerations of cost effectiveness. Ann Acad Med Singapore 1988;17:473-6.
29. Burden AD, Muston H, Beck MH. Intolerance and contact allergy to tar and dithranol in psoriasis. Contact Dermatitis 1994;31:185-6.
30. Roesyanto ID, van den Akker TW, van Joost TW. Wood tars allergy, cross-sensitization and coal tar. Contact Dermatitis 1990;22:95-8.
31. Burden AD, Stapleton M, Beck MH. Dithranol allergy: fact or fiction?. Contact Dermatitis 1992;27:291-3.
32. Condé-Salazar L, Guimaraens D, Romero LV, et al. Occupational coal tar dermatitis. Contact Dermatitis 1987;16:231.
33. Illchyshyn A, Cartwright, Smith AG. Contact sensitivity to newsprint: a rare manifestation of coal tar allergy. Contact Dermatitis 1987;17:52-3.
34. Gould JW, Mercuric MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. JAAD 1995;33:551-73.
35. Sugai T, Takahashi Y, Kakagi T, Pigmented cosmetic dermatitis and coal tar dyes. Contact Dermatitis 1977;3:249-56.
36. Kaidbey KH, Kligman AM. A human model of coal tar acne. Arch Dermatol 1974;109:212-5.
37. Ibbotson SH, Stenton SC, Simpson NB. Acute severe bronchoconstriction precipitated by coal tar bandages. Clin Exp Dermatol 1995;20:58-9.
38. Wright MC, Kaufhold A, Hevert F, et al. Untersuchungen zur möglichen Nephrotoxizität eines steinkohlenteerhalrigen Dermatikums. Hautarzt 1992;43:483-6.
39. Roder H. Lebensbedrohliche Vergiftung bei örtlicher Psoriasisbehandlung. Z Hautkr 1960;29:175-80.
40. Pion IA, Koening KL, Lim HW. Is dermatologic usage of coal tar carcinogenic? A review of the literature. Dermatol Surg 1995;21:227-31.
41. Jongeneelen FJ, Bos RP, Azion RBM, et al. Biological monitoring of polycyclic aromatic hydrocarbons. Metabolites in urine. Scand J Work Environ Health 1986;12:137-43.
42. Hansen AM, Poulsen OM, Menné T. Longitudinal Study of excretion of metabolites of polycyclic aromatic hydrocarbons in urine from two psoriatic patients. Acta Derm Venereol (Stockh) 1993;73:188-90.
43. Storer JS, DeLeon I, Millikan LE, et al. Human absorption of crude coal tar products. Arch Dermatol 1984;120:874-7.
44. Jones SK, Mackie RM, Hole DJ, et al. Further evidence of the safety of tar in the management of psoriasis. Br J Dermatol 1985;113:97-101.
45. Everall JD, Hansteen I-L, Lawler SD. Chromosome studies in pitch warts. Br J Dermatol 1967;79:271-7.
46. Brownstein MH, Rabinowitz AD. The precursors of cutaneous squamous cell carcinoma. Int J Dermatol 1979;18: 1-16.
47. Emmett EA. Cutaneous and ocular hazards of roofers. Occup Med 1986;1:307-22.
48. Maughan WZ, Muller SA, Perry HO, et al. Incidence of skin cancers in patients with atopic dermatitis treated with coal tar. A 25-year follow-up study. J Am Acad Dermatol 1980;3:612-5.
49. Pittelkow MR, Perry HO, Muller SA, et al. Incidence of skin cancers in psoriatic patients treated with coal tar: a 25-year follow-up study. Arch Dermatol 1981;117:465-8.
50. Larko O, Swanbeck G. Is UVB treatment safe? A study of extensively UVB treated psoriasis patients compared with a matched control group. Acta Derm Venereol (Stockh) 1982;62:502-12.
51. Stern RS, Zierler S, Parrish JA. Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet 1980;i:732-5.
52. Lindelöf B, Sigurgeirsson B. PUVA and cancer: a case-control study. Br J Dermatol 1993;129:39-41.
53. Zangar RC, Springer DL, Buschbom RL, et al. Comparison of fetotoxic effects of a dermally applied complex organic mixture in rats and mice. Fundam Appl Toxicol 1989;13:662-9.
54. Arnold WP, Boelen RE, van de Kerkhot PCM. De lokale behandeling van dermatosen bij zwangere vrouwen. Ned Tijdschr Geneeskd 1995;139:1170-3.